TY  - GEN
AU  - Muñoz-Gómez, María José
AU  - Ryan, Pablo
AU  - Quero-Delgado, Marta
AU  - Martin-Vicente, Maria
AU  - Cuevas, Guillermo
AU  - Valencia, Jorge
AU  - Jiménez, Eva
AU  - Blanca-López, Natalia
AU  - Lara-Álvarez, Miguel Ángel
AU  - Hernández-Rivas, José Ángel
AU  - Redondo, Gerardo
AU  - Mas-Lloret, Vicente
AU  - Sepulveda-Crespo, Daniel
AU  - Vazquez-Alcaraz, Monica
AU  - Torres-Macho, Juan
AU  - Martinez, Isidoro
AU  - Resino, Salvador
PY  - 2024
DO  - 10.1016/j.jiph.2024.102473
UR  - http://hdl.handle.net/20.500.12105/19881
AB  - Background: Cancer patients often have weakened immune systems, resulting in a lower response to vaccines, especially those receiving immunosuppressive oncological treatment (OT). We aimed to assess the impact of OT on the humoral and T-cell response...
LA  - eng
PB  - Elsevier
KW  - SARS-CoV-2
KW  - COVID-19 vaccine
KW  - Immune responses
KW  - B.1 lineage
KW  - Omicron variant
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Spike Glycoprotein, Coronavirus
KW  - SARS-CoV-2
KW  - Neoplasms
KW  - Antibodies, Viral
KW  - Humans
KW  - Prospective Studies
KW  - Male
KW  - Female
KW  - Middle Aged
KW  - Aged
KW  - T-Lymphocytes
KW  - Immunization, Secondary
KW  - Vaccination
KW  - Adult
KW  - Immunity, Humoral
KW  - Immunoglobulin G
KW  - Immunocompromised Host
KW  - Immunity, Cellular
TI  - Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study
TY  - research article
ER  -